Evaluation of Gixam's Performance in a FIT Negative Population

Recruiting Phase 2 Interventional Study
Colorectal Adenoma Colorectal Cancer (CRC) Colorectal Cancer (CRC) Screening
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
45 – 85
Sex
Any
Trial phase
Phase 2
Study type
Interventional
Purpose
Screening
Participants needed
400 (estimated)
Sponsor
Jubaan Ltd. · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
In the United States, colorectal cancer ranks second to lung cancer as a cause of cancer death and is the third most commonly occurring cancer in both men and women. Colorectal cancer in most cases develops slowly over a period of years, starting with the growth of precancerous polyps on the colon or rectum wall. The slow development of colorectal cancer makes it possible to detect and prevent it …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Subjects aged 45-85 years. 2. Able to provide a signed informed consent. 3. Scheduled for a screening colonoscopy at the investigation site. Exclusion Criteria: 1. Undergoing diagnostic colonoscopy for investigation of symptoms. 2. Has undergone colonoscopy within preceding…
Contacts

Daniella Bleistein

+972549599353

daniella@jubaan.com

CONTACT